Wikidata

(Q61956771)

English

A Study of Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/ml

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

short name
New Switch (English)
0 references
title
A Randomized, Multicenter Study Evaluating HBsAg Clearance in CHB Patients Achieving HBeAg Loss and HBV DNA <200copies/ml on Treatment With Nucleotide Analogues and Switched to Peginterferon Alfa-2a (English)
0 references
start time
October 2011
0 references
end time
June 2016
0 references
number of participants
300
0 references
minimum age
18 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61956771&oldid=2170784840"